Molecular Cancer,
Journal Year:
2022,
Volume and Issue:
21(1)
Published: April 11, 2022
The
tumor
microenvironment
(TME)
is
essential
for
immune
escape
by
cells.
It
plays
roles
in
development
and
metastasis.
clinical
outcomes
of
tumors
are
often
closely
related
to
individual
differences
the
patient
TME.
Therefore,
reprogramming
TME
cells
their
intercellular
communication
an
attractive
promising
strategy
cancer
therapy.
consist
nonimmune
These
need
be
manipulated
precisely
safely
improve
Furthermore,
it
encouraging
that
this
field
has
rapidly
developed
recent
years
with
advent
gene
editing
technologies.
In
review,
we
briefly
introduce
technologies
systematically
summarize
applications
precision
therapy,
including
communication.
cell
can
regulate
differentiation,
proliferation,
function.
Moreover,
optimize
infiltration
specific
recognition
Thus,
will
pave
way
further
breakthroughs
Cell,
Journal Year:
2023,
Volume and Issue:
186(8), P. 1729 - 1754
Published: April 1, 2023
Pancreatic
ductal
adenocarcinoma
(PDAC)
remains
one
of
the
deadliest
cancers.
Significant
efforts
have
largely
defined
major
genetic
factors
driving
PDAC
pathogenesis
and
progression.
tumors
are
characterized
by
a
complex
microenvironment
that
orchestrates
metabolic
alterations
supports
milieu
interactions
among
various
cell
types
within
this
niche.
In
review,
we
highlight
foundational
studies
driven
our
understanding
these
processes.
We
further
discuss
recent
technological
advances
continue
to
expand
complexity.
posit
clinical
translation
research
endeavors
will
enhance
currently
dismal
survival
rate
recalcitrant
disease.
Cell,
Journal Year:
2021,
Volume and Issue:
184(25), P. 6119 - 6137.e26
Published: Dec. 1, 2021
Prognostically
relevant
RNA
expression
states
exist
in
pancreatic
ductal
adenocarcinoma
(PDAC),
but
our
understanding
of
their
drivers,
stability,
and
relationship
to
therapeutic
response
is
limited.To
examine
these
attributes
systematically,
we
profiled
metastatic
biopsies
matched
organoid
models
at
single-cell
resolution.In
vivo,
identify
a
new
intermediate
PDAC
transcriptional
cell
state
uncover
distinct
site-and
state-specific
tumor
microenvironments
(TMEs).Benchmarking
against
this
reference
map,
reveal
strong
culture-specific
biases
cancer
representation
driven
by
altered
TME
signals.We
restore
heterogeneity
adding
back
vivo-relevant
factors
show
plasticity
culture
models.Further,
prove
that
non-genetic
modulation
can
strongly
influence
drug
responses,
uncovering
vulnerabilities.This
work
provides
broadly
applicable
framework
for
aligning
across
vivo
ex
settings,
identifying
drivers
manipulating
target
associated
vulnerabilities.
Annual Review of Pathology Mechanisms of Disease,
Journal Year:
2022,
Volume and Issue:
18(1), P. 123 - 148
Published: Sept. 21, 2022
Pancreatic
ductal
adenocarcinoma
(PDAC)
features
a
prominent
stromal
microenvironment
with
remarkable
cellular
and
spatial
heterogeneity
that
meaningfully
impacts
disease
biology
treatment
resistance.
Recent
advances
in
tissue
imaging
capabilities,
single-cell
analytics,
modeling
have
shed
light
on
organizing
principles
shape
the
complexity
of
PDAC
tumors.
These
insights
into
functional
dependencies
coordinate
cancer
cell
relationships
exist
between
cells
extracellular
matrix
components
present
tumors
are
expected
to
unveil
therapeutic
vulnerabilities.
We
review
recent
field
discuss
current
understandings
mechanisms
by
which
tumor
shapes
pathogenesis
therapy
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Feb. 13, 2023
The
tumor
microenvironment
(TME)
in
pancreatic
ductal
adenocarcinoma
(PDAC)
is
a
complex
ecosystem
that
drives
progression;
however,
in-depth
single
cell
characterization
of
the
PDAC
TME
and
its
role
response
to
therapy
lacking.
Here,
we
perform
single-cell
RNA
sequencing
on
freshly
collected
human
samples
either
before
or
after
chemotherapy.
Overall,
find
heterogeneous
mixture
basal
classical
cancer
subtypes,
along
with
distinct
cancer-associated
fibroblast
macrophage
subpopulations.
Strikingly,
basal-like
cells
exhibit
similar
transcriptional
responses
chemotherapy
do
not
demonstrate
shift
towards
program
among
treated
samples.
We
observe
decreased
ligand-receptor
interactions
samples,
particularly
between
TIGIT
CD8
+
T
receptor
cells,
identify
as
major
inhibitory
checkpoint
molecule
cells.
Our
results
suggest
profoundly
impacts
may
promote
resistance
immunotherapy.
Cell Research,
Journal Year:
2023,
Volume and Issue:
33(8), P. 585 - 603
Published: June 19, 2023
Abstract
Dissecting
and
understanding
the
cancer
ecosystem,
especially
that
around
tumor
margins,
which
have
strong
implications
for
cell
infiltration
invasion,
are
essential
exploring
mechanisms
of
metastasis
developing
effective
new
treatments.
Using
a
novel
border
scanning
digitization
model
enabled
by
nanoscale
resolution-SpaTial
Enhanced
REsolution
Omics-sequencing
(Stereo-seq),
we
identified
500
µm-wide
zone
centered
in
patients
with
liver
cancer,
referred
to
as
“the
invasive
zone”.
We
detected
immunosuppression,
metabolic
reprogramming,
severely
damaged
hepatocytes
this
zone.
also
subpopulation
increased
expression
serum
amyloid
A1
A2
(referred
collectively
SAAs)
located
close
on
paratumor
side.
Overexpression
CXCL6
adjacent
malignant
cells
could
induce
activation
JAK-STAT3
pathway
nearby
hepatocytes,
subsequently
caused
SAAs’
overexpression
these
hepatocytes.
Furthermore,
secretion
SAAs
lead
recruitment
macrophages
M2
polarization,
further
promoting
local
potentially
resulting
progression.
Clinical
association
analysis
additional
five
independent
cohorts
primary
secondary
(
n
=
423)
showed
had
worse
prognosis.
Further
vivo
experiments
using
mouse
models
situ
confirmed
knockdown
genes
encoding
decreased
macrophage
accumulation
delayed
growth.
The
identification
characterization
human
not
only
add
an
important
layer
regarding
invasion
metastasis,
but
may
pave
way
therapeutic
strategies
advanced
other
solid
tumors.